Evidence map›Paper›PMID 40849429›Full record

ArticleTranslational psychiatry2025

Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms.

Trevor F Williams, James M Gold, James A Waltz, Jason Schiffman, Lauren M Ellman, Gregory P Strauss, Elaine F Walker, Scott W Woods, Albert R Powers, Joshua Kenney and 6 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. The problem of recognition of clinical high-risk states is hampering the prevention of schizophrenia.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Trevor F WilliamsDepartment of Psychology, Kent State University, Kent, OH, 44242, USA. twill253@kent.edu.ORCID http://orcid.org/0000-0003-2202-7020
James M GoldMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, 21228, USA.
James A WaltzMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, 21228, USA.ORCID http://orcid.org/0000-0002-9236-3719
Jason SchiffmanDepartment of Psychological Science, 4201 Social and Behavioral Sciences Gateway, University of California, Irvine, CA, 92697, USA.
Lauren M EllmanDepartment of Psychology & Neuroscience, Temple University, Philadelphia, PA, 19122, USA.
Gregory P StraussDepartments of Psychology and Neuroscience, University of Georgia, Athens, GA, 30602, USA.
Elaine F WalkerDepartment of Psychology and Program in Neuroscience, Emory University, Atlanta, GA, 30322, USA.ORCID http://orcid.org/0000-0002-9798-8101
Scott W WoodsDepartment of Psychiatry, Yale University, New Haven, CT, 06519, USA.ORCID http://orcid.org/0000-0002-3103-5228
Albert R PowersDepartment of Psychiatry, Yale University, New Haven, CT, 06519, USA.ORCID http://orcid.org/0000-0003-3057-5043
Joshua KenneyDepartment of Psychiatry, Yale University, New Haven, CT, 06519, USA.
Minerva K PappuDepartment of Psychiatry, Yale University, New Haven, CT, 06519, USA.
Philip R CorlettDepartment of Psychiatry, Yale University, New Haven, CT, 06519, USA.ORCID http://orcid.org/0000-0002-5368-1992
Tanya TranDepartments of Psychiatry, Neuroscience and Ophthalmology, University of Rochester Medical Center, Rochester, NY, 14642, USA.ORCID http://orcid.org/0000-0002-6303-8394
Steven M SilversteinDepartments of Psychiatry, Neuroscience and Ophthalmology, University of Rochester Medical Center, Rochester, NY, 14642, USA.
Richard E ZinbargDepartment of Psychology, Northwestern University, Evanston, IL, 60208, USA.
Vijay A MittalInstitutes for Policy Research (IPR) and Innovations in Developmental Sciences (DevSci), Departments of Psychology, Psychiatry, Medical Social Sciences, Northwestern University, Evanston, IL, 60208, USA.ORCID http://orcid.org/0000-0001-9017-5119

Funding

5/5 CAPER: Computerized Assessment of Psychosis RiskR01MH120089 · NIMH · YALE UNIVERSITY · PI CORLETT, PHILIP, WOODS, SCOTT W · 2020 to 2024
$3.1M
1/5 CAPER: Computerized Assessment of ProdromE RiskR01MH120090 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI GOLD, JAMES M. · 2020 to 2024
$2.9M
4/5 CAPER: Computerized assessment of psychosis riskR01MH120092 · NIMH · UNIVERSITY OF GEORGIA · PI STRAUSS, GREGORY P · 2020 to 2024
$2.0M
CAPER: Computerized Assessment of Psychosis Risk SupplementR01MH120091 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLMAN, LAUREN M · 2020 to 2024
$1.6M
Paranoia and Bias in Social Belief Updating in Clinical High Risk for PsychosisF32MH133302 · NIMH · NORTHWESTERN UNIVERSITY · PI WILLIAMS, TREVOR FORD · 2023 to 2023
$69k
NIMH NIH HHS F32 MH133302NIMH NIH HHS R01 MH120089NIMH NIH HHS R01 MH120090NIMH NIH HHS R01 MH120091NIMH NIH HHS R01 MH120092U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) F32MH133302U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH120089U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH120090U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH120091U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH120092
6 · The paper itself

Abstract

The clinical high risk for psychosis (CHR-P) population is important for understanding disease progression and treatment; however, standard approaches to identifying CHR-P individuals are expensive and labor-intensive. Focusing on neurocognitive mechanisms that underlie individual psychosis symptoms (positive, negative, and disorganization) may improve screening and identification. The present study examines whether a behavioral task battery that assays symptom mechanisms can identify CHR-P individuals and predict risk severity. Participants (N = 621) were recruited from clinics and the community as part of the Computerized Assessment of Psychosis Risk (CAPR) consortium study. Structured clinical interviews, a dimensional risk calculator, and behavioral tasks were administered. Clinical interviews identified the following groups: (a) CHR-P (n = 273), (b) non-CHR-P individuals with limited psychosis like experiences (PLEs; n = 120), (c) participants with mental disorders and no PLEs (CLN; n = 82), and (d) healthy controls (HC; n = 146). Multinomial logistic regression indicated that the task battery differentiated groups (p < 0.001), with utility for identifying CHR-P individuals (Sensitivity = 0.87, PPV = 0.51, NPV = 0.77), though with high false positives that varied based on comparison group (Specificity = 0.21-0.43). Tasks also predicted psychosis risk calculator scores (Adjusted R

Indexed as

Neuropsychological TestsPsychotic DisordersAdolescentAdultFemaleHumansMaleProdromal SymptomsRisk AssessmentYoung Adult

Identifiers

PMID40849429
PMCPMC12375010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.